|
GANAB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.688200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.327580E-01 |
| Normal-vs-Stage2 |
7.602600E-01 |
| Normal-vs-Stage3 |
1.001160E-03 |
| Normal-vs-Stage4 |
7.864500E-03 |
| Stage1-vs-Stage2 |
1.447420E-01 |
| Stage1-vs-Stage3 |
1.031590E-02 |
| Stage1-vs-Stage4 |
9.832000E-02 |
| Stage2-vs-Stage3 |
6.096200E-03 |
| Stage2-vs-Stage4 |
1.966280E-02 |
| Stage3-vs-Stage4 |
7.903000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.587610E-02 |
| Normal-vs-AfricanAmerican |
4.979800E-01 |
| Normal-vs-Asian |
1.451970E-01 |
| Caucasian-vs-AfricanAmerican |
3.344600E-01 |
| Caucasian-vs-Asian |
3.529000E-01 |
| AfricanAmerican-vs-Asian |
6.869400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.533800E-02 |
| Normal-vs-Female |
6.013900E-02 |
| Male-vs-Female |
9.170200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.252400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.345960E-01 |
| Normal-vs-Age(61-80Yrs) |
1.068330E-02 |
| Normal-vs-Age(81-100Yrs) |
1.514490E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.294000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.066400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.449430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.298970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.827820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.944800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.523000E-03 |
| Classical-VS-Follicular |
1.851000E-01 |
| Classical-VS-Other |
4.657200E-01 |
| Classical-VS-Normal |
6.789700E-02 |
| Tall-VS-Follicular |
3.795000E-04 |
| Tall-VS-Other |
4.319400E-01 |
| Tall-VS-Normal |
7.77680000000336E-05 |
| Follicular-VS-Other |
3.586600E-01 |
| Follicular-VS-Normal |
7.624000E-01 |
| Other-VS-Normal |
1.419830E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.464600E-01 |
| Normal-vs-N1 |
4.16119999999687E-05 |
| N0-vs-N1 |
5.980400E-04 |
|
|
